Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma.

NCT03540407 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Carcinoma Stage II
Cervical Carcinoma Stage III
Cervical Carcinoma Stage IV
Endometrial Adenocarcinoma Stage II
Endometrial Adenocarcinoma Stage III
Endometrial Adenocarcinoma Stage IV

Interventions

DIETARY_SUPPLEMENT: Oncoxin-Viusid®
DIETARY_SUPPLEMENT: Placebo

Sponsor

Catalysis SL